| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.014 | 0.6 |